Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Rajnish Wellness to set up healthcare focused wellness centres at 270 stations over Eastern Railway on license basis for 5 years Business
  • Meet Suchismita Pattnaik: The Women Who Bagged Two Titles Of Mrs. Universe 2021 In South Korea Lifestyle
  • Sathlokhar Synergys E&C Global Limited Secures INR 35.61 Cr Repeat Order from Reliance Consumer Products; Order Book at INR 1,252.16 Cr Press Release
  • Sakhiya Skin Clinic: Trusted Experts in Skincare and Aesthetic Treatments Business
  • Alpha Healing Centre collaborates with Adayu to strengthen rehabilitation and de-addiction services Health
  • Ivana Jewels unveils first TVC with Mouni Roy in the spotlight Business
  • Dr Avanii Rajadhyaksha’s Spiritual Mela inaugurated by Gopal Shetty (MP) Business
  • Data Trained announces the launch of its new venture, DT Evolve Press Release

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • TRANSFORM II Trial Hits Enrollment Milestone: Redefining Coronary Care with Sirolimus-Coated Balloons Health
  • Dr. V.V. Manjula Kumari Honoured with Karmaveer Global Fellowship and Gold Medal Health
  • SBI Foundation MD Sanjay Prakash and Dr. Dharmendra Kumar Join TB-Free Maha Arogya Shivir Health
  • Concept Medical’s 3-Year SIRONA Data Brings Long-Term Outcomes Back Into the Conversation Health
  • How Much Sleep You Actually Need Health
  • Zenzo Leads the Way with 5G-Enabled Ambulances for Seamless Healthcare Delivery in Mumbai Health

Recent Posts

  • Subhash Choudhary : The ‘Accidental CTO’ whose journey from Bihar has been an engineering bestseller, has a net worth of Rs. 203 Crore.
  • From Vision to Legacy: How Jatin Manodra Built Double Bull into a Men’s Fashion Brand with Purpose
  • Whosthat360 Initiative Oriflame Presents WhosNext2026 Influencer Awards – East & Northeast Edition to Host a Grand Finale in Kolkata
  • Patil Automation Posts Robust FY26 Performance; PAT Jumps 35%, Revenue Up 28%
  • PayRupik Bags Top Honour for Customer Experience at Global LendTech Summit 2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Aru K Verma Unveils Mango Media Works, a Distinctive Hub for Film Production and Education! Entertainment
  • BE Hub Launches in Pune to Empower Grassroots Entrepreneurs of Bharat Business
  • Challenging market environment shapes third quarter of 2025 – LANXESS Business
  • The Compelling Case for Multi-Asset Allocation Funds Business
  • Aparna Satheesan Recipient of 2021 Abhinandan Saroja National Award By the National Institute of Indian Classical Dance Lifestyle
  • Zapllo Technologies Launches Task Delegation App Business
  • Policy Execution and Administrative Excellence at FCI: Observations Shared by Sudeep Singh FCI Lifestyle
  • VCare Launches Centre of Excellence, Introducing Single-Day Facial Architecture Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme